http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007128702-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e06ba6bcf368ab295aad7d7beb3333b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74 |
| filingDate | 2006-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_027662920d57a718d00388dd2b192fd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_034110ce792015923d9110597601efbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba68835fa3562910699b0fa9b4f6fd61 |
| publicationDate | 2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2007128702-A1 |
| titleOfInvention | Methods of creating consumable strains and compositions thereof |
| abstract | Consumable biotech strain improvement products are presented, as well as methods of preparation and using them. The technology is based on reversible, single-crossover insertion vectors, such as plasmids or phage. Because the single crossover event is reversible in the absence of drug selection, the products cannot be maintained in a useful form without knowledge of the drug selection agent. Consumable strain improvement products can be constructed with 1st generation reverse engineering protections, having at least 25%-75% of the effectiveness of the equivalent traditional (permanent) strain improvement product under laboratory condition. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108251331-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111139192-A |
| priorityDate | 2005-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1101.